Major bleeding and thromboembolic complications associated with antithrombotic treatment in patients with atrial fibrillation/flutter and incident cancer
Patients with AF with certain incident cancer types experienced higher rates of MB and TE than those without cancer. Dual/triple antithrombotic therapy in patients with AF with incident cancer was associated with high bleeding rates, particularly with gastrointestinal cancer.
Authors
- Henrik Toft Sørensen (ORCID: https://orcid.org/0000-0003-4299-7040)
- Gordon Chu (ORCID: https://orcid.org/0000-0001-5466-3094)
- Frederikus Albertus Klok (ORCID: https://orcid.org/0000-0001-9961-0754)
- Nienke van Rein (ORCID: https://orcid.org/0000-0001-9201-401X)
- Lars Pedersen (ORCID: https://orcid.org/0000-0002-9341-3888)
- Menno V. Huisman
- Suzanne C Cannegieter
Institutions
- Leiden University (NL)
- Leiden University Medical Center (NL)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/j.rpth.2025.102697
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00